首页> 美国卫生研究院文献>Cells >The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells
【2h】

The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells

机译:甲状腺刺激激素受体在癌细胞中的分子功能及临床作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The thyroid stimulating hormone (TSH) and its cognate receptor (TSHR) are of crucial importance for thyrocytes to proliferate and exert their functions. Although TSHR is predominantly expressed in thyrocytes, several studies have revealed that functional TSHR can also be detected in many extra-thyroid tissues, such as primary ovarian and hepatic tissues as well as their corresponding malignancies. Recent advances in cancer biology further raise the possibility of utilizing TSH and/or TSHR as a therapeutic target or as an informative index to predict treatment responses in cancer patients. The TSH/TSHR cascade has been considered a pivotal modulator for carcinogenesis and/or tumor progression in these cancers. TSHR belongs to a sub-group of family A G-protein-coupled receptors (GPCRs), which activate a bundle of well-defined signaling transduction pathways to enhance cell renewal in response to external stimuli. In this review, recent findings regarding the molecular basis of TSH/TSHR functions in either thyroid or extra-thyroid tissues and the potential of directly targeting TSHR as an anticancer strategy are summarized and discussed.
机译:甲状腺刺激激素(TSH)及其同源受体(TSHR)对甲茂细胞来说至关重要,以增殖并施加其功能。虽然TSHR主要在甲基yrocytes中表达,但是若干研究表明,在许多额外的甲状腺组织中也可以检测到功能性TSHR,例如原发性卵巢和肝脏组织以及它们相应的恶性肿瘤。癌症生物学的最新进展进一步提高了利用TSH和/或TSHR作为治疗目标或作为预测癌症患者治疗反应的信息指数的可能性。 TSH / TSHR级联被认为是这些癌症中的致癌和/或肿瘤进展的枢转调节剂。 TSHR属于家族的亚组G蛋白偶联受体(GPCR),其激活一束明确定义的信号转导途径,以响应外部刺激而增强细胞更新。在本次综述中,关于甲状腺或超甲状腺组织中TSH / TSHR功能的分子基础的最近发现以及直接靶向TSHR作为抗癌策略的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号